[Form 4] Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Insider sales by Vita Coco CEO and related trusts. Martin Roper reported multiple Rule 10b5-1 sales of common stock on September 24-25, 2025, disposing of blocks of 5,000 and 400 shares at weighted average prices in the ~$40.00–$41.67 range. After these transactions the reporting person directly held 319,297 shares. Related family trusts and spouses show indirect holdings ranging from 252,515 to 253,931 shares, and an additional 61,200 shares are held by a spouse. The filing also discloses large outstanding stock option positions fully exercisable or vesting across 2022–2026, totaling several hundred thousand underlying shares.

Positive

• Sales were executed under a Rule 10b5-1 trading plan, which signals preplanned transactions rather than opportunistic insider timing
• Reporting includes full disclosure of weighted-average price ranges and identification of indirect holdings by family trusts and spouse
• Reporting person retains substantial equity and option exposure (directly 319,297 shares plus large outstanding option positions)

Negative

• Insider sold shares in the open market, reducing direct holdings, which may be interpreted as insider liquidity
• Large number of outstanding options could be dilutive when exercised given hundreds of thousands of underlying shares

Insights

Securities Analyst

TL;DR: CEO executed preplanned sales under a 10b5-1 plan, reducing direct holdings modestly while retaining substantial equity and option exposure.

The Form 4 shows routine disposition activity executed pursuant to Rule 10b5-1 trading plans on September 24–25, 2025. Total reported disposals per line items are small relative to the aggregate direct and indirect holdings; the reporting person still directly owns 319,297 shares. The filing also enumerates sizeable stock option grants across multiple strike prices and vesting schedules, including large fully exercisable options at $10.178 and later-dated grants vesting through 2026. For investors, this indicates continued insider liquidity but persistent insider alignment via retained shares and options.

Corporate Governance Expert

TL;DR: Disclosures are compliant and transparent; sales were executed under 10b5-1 and explanations include weighted-average price ranges.

The filer provided the required disclosure elements: transaction dates, codes, number of shares sold, weighted-average price ranges, and the 10b5-1 plan disclosure. Indirect ownership through three family trusts and a spouse is clearly identified. The signature is by an attorney-in-fact on behalf of Martin Roper. There are no indications of late reporting or missing mandatory fields in the provided text. This is a routine insider disclosure consistent with governance norms.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Roper Martin

(Last) (First) (Middle)

250 PARK AVE SOUTH

SEVENTH FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/24/2025		S(1)		5,000	D	$41.323(2)	319,297	D
Common Stock	09/25/2025		S(1)		400	D	$40.165(3)	318,897	D
Common Stock	09/24/2025		S(1)		5,000	D	$41.253(4)	253,806	I	by Chris Roper FT(5)
Common Stock	09/25/2025		S(1)		400	D	$40.17(6)	253,406	I	by Chris Roper FT(5)
Common Stock	09/24/2025		S(1)		5,000	D	$41.32(7)	252,915	I	by Peter Roper FT(8)
Common Stock	09/25/2025		S(1)		400	D	$40.165(9)	252,515	I	by Peter Roper FT(8)
Common Stock	09/24/2025		S(1)		5,000	D	$41.321(10)	253,931	I	by Thomas Roper FT(11)
Common Stock	09/25/2025		S(1)		400	D	$40.165(12)	253,531	I	by Thomas Roper FT(11)
Common Stock								61,200	I	by Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$10.178							(13)	09/19/2029	Common Stock	579,670		579,670	D
Non-Qualified Stock Option (right to buy)	$10.178							(14)	01/11/2031	Common Stock	40,950		40,950	D
Non-Qualified Stock Option (right to buy)	$15							(15)	10/21/2031	Common Stock	298,507		298,507	D
Non-Qualified Stock Option (right to buy)	$16.91							(16)	03/10/2033	Common Stock	46,875		46,875	D
Non-Qualified Stock Option (right to buy)	$26.18							(17)	03/04/2034	Common Stock	62,743		62,743	D
Non-Qualified Stock Option (right to buy)	$32.78							(18)	03/03/2035	Common Stock	70,715		70,715	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.73 to $41.67, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.22, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.73 to $41.67, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

5. These shares are held by the Christopher G. Roper Exempt Family Trust.

6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.02 to $40.22, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.73 to $41.65, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

8. These shares are held by the Peter S. Roper Exempt Family Trust.

9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.22, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.73 to $41.64, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

11. These shares are held by the Thomas L. Roper Exempt Family Trust.

12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.22, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

13. The stock option is fully vested and currently exercisable.

14. The stock option is fully vested and currently exercisable.

15. The stock option vests in four equal annual installments beginning on November 27, 2022.

16. The stock option vests in four equal annual installments beginning on March 10, 2024.

17. The stock option vests in four equal annual installments beginning on March 4, 2025.

18. The Stock Option vests in four equal annual installments beginning in March 3, 2026.

	By: Alison Klein, Attorney-in-Fact For: Martin Roper	09/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What shares did Martin Roper sell according to the COCO Form 4?

The Form 4 reports sales on 09/24/2025 and 09/25/2025 of blocks of 5,000 and 400 common shares executed under a Rule 10b5-1 trading plan.

At what prices were the COCO shares sold in the filing?

The filing reports weighted-average prices with ranges approximately from $40.00 to $41.67 across the reported transactions.

How many COCO shares does Martin Roper directly own after the reported transactions?

After the reported transactions the filing shows Martin Roper directly beneficially owning 319,297 shares.

Does the Form 4 disclose derivative securities for COCO?

Yes. The filing lists multiple non-qualified stock options covering hundreds of thousands of underlying shares with various strike prices and vesting schedules, including fully exercisable options at $10.178.

Are any indirect holdings disclosed in the COCO Form 4?

Yes. Indirect holdings are reported through the Christopher G. Roper, Peter S. Roper, and Thomas L. Roper Exempt Family Trusts and a spouse, with indirect share counts in the low 250,000s and 61,200 shares held by a spouse.